๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia

โœ Scribed by Nicole Lamanna; Mark A. Weiss

Book ID
107546621
Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
169 KB
Volume
10
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Rituximab in chronic lymphocytic leukemi
Rituximab in chronic lymphocytic leukemia
โœ Danelle F. James; Thomas J. Kipps ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Springer Healthcare Communications ๐ŸŒ English โš– 846 KB
Consolidation and maintenance immunother
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia
โœ Giovanni Del Poeta; Maria Ilaria Del Principe; Francesco Buccisano; Luca Maurill ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 186 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. Rituximab in sequential combination with fludarabine (Flu) allowed patients with Bโ€cell chronic lymphocytic leukemia (Bโ€CLL) to achieve higher remission rates and longer response duration. Based on their recent experience in indolent nonโ€Hodgkin lymphomas, in this study,

Rituximab therapy for chronic lymphocyti
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
โœ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W